Pyxis Oncology, Inc.

NasdaqGS:PYXS Stock Report

Market Cap: US$247.4m

Pyxis Oncology Management

Management criteria checks 3/4

Pyxis Oncology's CEO is Lara Sullivan, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is $4.44M, comprised of 14.1% salary and 85.9% bonuses, including company stock and options. directly owns 3.14% of the company’s shares, worth $7.76M. The average tenure of the management team and the board of directors is 2.8 years and 3.2 years respectively.

Key information

Lara Sullivan

Chief executive officer

US$4.4m

Total compensation

CEO salary percentage14.1%
CEO tenure4.9yrs
CEO ownership3.1%
Management average tenure2.8yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Moment Of Truth Approaches For Pyxis Oncology

Sep 13

Pyxis Oncology: Promising Research Amid Cash Constraints

Jun 10

Pyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Wait

Mar 28

Pyxis Oncology: Making A Bold Acquisition Move, But It's Not A Convincing Thesis

Jan 18

Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?

Feb 18
Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?

Here's Why We're Watching Pyxis Oncology's (NASDAQ:PYXS) Cash Burn Situation

Sep 01
Here's Why We're Watching Pyxis Oncology's (NASDAQ:PYXS) Cash Burn Situation

Pyxis Oncology GAAP EPS of -$0.79 beats by $0.06

Aug 15

We're Hopeful That Pyxis Oncology (NASDAQ:PYXS) Will Use Its Cash Wisely

Apr 13
We're Hopeful That Pyxis Oncology (NASDAQ:PYXS) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Lara Sullivan's remuneration changed compared to Pyxis Oncology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$57m

Jun 30 2024n/an/a

-US$59m

Mar 31 2024n/an/a

-US$58m

Dec 31 2023US$4mUS$625k

-US$74m

Sep 30 2023n/an/a

-US$94m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$109m

Dec 31 2022US$5mUS$565k

-US$121m

Sep 30 2022n/an/a

-US$101m

Jun 30 2022n/an/a

-US$88m

Mar 31 2022n/an/a

-US$71m

Dec 31 2021US$17mUS$565k

-US$76m

Sep 30 2021n/an/a

-US$64m

Jun 30 2021n/an/a

-US$53m

Mar 31 2021n/an/a

-US$47m

Dec 31 2020US$555kUS$375k

-US$13m

Compensation vs Market: Lara's total compensation ($USD4.44M) is above average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Lara's compensation has been consistent with company performance over the past year.

CEO

Lara Sullivan

4.9yrs

Tenure

US$4,442,501

Compensation

Dr. Lara S. Sullivan, M.D., MBA, has been Chief Executive Officer, President and Director at Pyxis Oncology, Inc. since December 2019. She was a Principal at Paul Capital Partners, since April 2007. Dr. Su...

Leadership Team

NamePositionTenureCompensationOwnership
Lara Sullivan
CEO, President & Director4.9yrsUS$4.44m3.14%
$ 7.8m
Pamela Connealy
CFO & COO3.3yrsUS$1.82m0.89%
$ 2.2m
Ken Kobayashi
Chief Medical Officerless than a yearUS$1.13mno data
Jitendra Wadhane
Chief Accounting Officer3.3yrsno data0.26%
$ 644.7k
Balu Balasubramanian
Interim Chief Technology Officer2.8yrsno datano data
Jan Pinkas
Chief Scientific Officer2.6yrsno datano data
Charles Gombar
Senior Vice President of Portfolio & Program Management2.8yrsno datano data
Stephen Worsley
Senior VP & Chief Business Officerless than a yearno datano data

2.8yrs

Average Tenure

61.5yo

Average Age

Experienced Management: PYXS's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lara Sullivan
CEO, President & Director4.9yrsUS$4.44m3.14%
$ 7.8m
John Flavin
Independent Chairman5.5yrsUS$395.48k0.64%
$ 1.6m
Anthony Tolcher
Member of Clinical & Translational Medicine Advisory Board3.4yrsno datano data
Freda Lewis-Hall
Independent Director3.2yrsUS$341.98k0.35%
$ 857.7k
Darren Cline
Independent Director3.2yrsUS$357.48k0.36%
$ 899.3k
Thomas Civik
Independent Director3.2yrsUS$360.48k0.37%
$ 923.0k
Jason J. Luke
Member of Clinical & Translational Medicine Advisory Boardno datano datano data
Christopher O'Donnell
Member of Technical Advisory Board2.6yrsno datano data
Morris Rosenberg
Chairperson of Technical Advisory Boardno datano datano data
Robert Baffi
Member of Technical Advisory Boardno datano datano data
Virgil Lawlis
Member of Technical Advisory Boardno datano datano data
Michael Sun
Member of Technical Advisory Boardno datano datano data

3.2yrs

Average Tenure

55yo

Average Age

Experienced Board: PYXS's board of directors are considered experienced (3.2 years average tenure).